- Home
- GHRS vs ESTA Comparison
GHRS vs ESTA Comparison
Compare GHRS & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GHRS | ESTA |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GHRS | ESTA |
|---|---|---|
| Price | $28.96 | $92.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $41.38 | ★ $86.86 |
| AVG Volume (30 Days) | 233.7K | ★ 724.3K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $61,208,000.00 |
| Revenue This Year | N/A | $28.05 |
| Revenue Next Year | N/A | $26.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 76.49 |
| 52 Week Low | $11.32 | $33.35 |
| 52 Week High | $31.00 | $93.12 |
Technical Indicators
Market Signals| Indicator | GHRS | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 65.84 | 65.99 |
| Support Level | $12.88 | $63.71 |
| Resistance Level | $28.96 | $92.84 |
| Average True Range (ATR) | 1.66 | 3.67 |
| MACD | 0.10 | -0.25 |
| Stochastic Oscillator | 65.92 | 92.88 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.